| Net Cash Provided by (Used in) Operating Activities |
$191,000 |
USD |
-95% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$410,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$5,747,000 |
USD |
33% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
47,691,121 |
shares |
1.4% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$6,348,000 |
USD |
9.2% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$11,172,000 |
USD |
90% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$5,760,000 |
USD |
-16% |
Q1 2025 |
Q1 2025 |
| Depreciation |
$92,000 |
USD |
-2.1% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$32,346,000 |
USD |
-923% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$3,904,000 |
USD |
2.1% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$257,600,000 |
USD |
0.5% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$100,000 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$1,000,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |